Genmab | Crediti Commerciali



Trade Debtors Cambiamento Data
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Almirall EUR 178.14M 31.11M 2024-06
Amarin USD 112.64M 11.05M 2024-09
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Bayer EUR 12.5B 1.33B 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Demant DKK 4.45B 141M 2024-12
Exelixis USD 265.44M 4.27M 2025-01
Fresenius Medical Care EUR 3.37B 123M 2024-12
Galapagos EUR 87.36M 133K 2024-12
Genmab DKK 6.69B 381M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
GN Store Nord DKK 386M 4.58B 2024-12
GRIFOLS EUR 871.58M 135.79M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
Insmed USD 52.01M 9.7M 2024-12
Lonza CHF 2B 406M 2024-12
Merck EUR 4.59B 127M 2024-12
Novartis USD 9B 854M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.8B 2.24B 2024-06
UCB EUR 1.42B 132M 2024-06



Genmab Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.